Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ToothWave Calculus Reduction and Accumulation Prevention Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04596761
Recruitment Status : Completed
First Posted : October 22, 2020
Last Update Posted : April 23, 2021
Sponsor:
Information provided by (Responsible Party):
Home Skinovations Ltd.

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The objective of the study is to evaluate the safety and efficacy of the home-use device ToothWave (Model H7001) for calculus reduction and the prevention of calculus accumulation.

Condition or disease Intervention/treatment Phase
Gingivitis Plaque Calculus, Dental Device: RF-utilizing powered toothbrush Device: Control placebo with no RF Not Applicable

Detailed Description:

This is a parallel group, single-blind, randomized, and controlled prospective study aimed to evaluate the safety and efficacy of the ToothWave in calculus reduction and prevention of calculus accumulation.

Eligible subjects will undergo a dental prophylaxis, and will enter a two-month run-in phase. A Volpe-Manhold Index (V-MI) calculus examination will be per-formed at the end of the run-in phase. A minimum of 90 qualified subjects (completers) who will form at least 9 mm of calculus on the lingual surface of the mandibular anterior teeth and will qualify to continue participation ac-cording to the eligibility criteria and will be randomly assigned to either the ToothWave or the control brush (ADA-accepted powered TB) group. Subjects will be stratified according to calculus levels (which indicates the calculus growth rate). Stratification will also be conducted according to age, gender, and ethnic group. Subjects will brush twice daily, unsupervised, during a three-month test period, returning at Weeks 3, 6 and 12 for safety and V-MI examinations. An additional visit will be conducted at week 9, during which a supervised brushing will be conducted.

The study test phase will include a total of 168 treatment sessions and 5 clinic visits over a period of 12 weeks.

For each subject, assessment data will be collected at baseline, and at 3, 6 and 12 weeks of the test phase. The average data sets will be calculated for each group.

Treatment is defined as a timed 2 minutes of teeth brushing in a regular manner, twice a day (morning and evening). Brushing will be undertaken using the ToothWave and standard fluoride toothpaste. The control group will use a regular powered toothbrush and standard fluoride toothpaste.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Single blind prospective study
Masking: Single (Outcomes Assessor)
Masking Description: The Outcomes Assessors will not be exposed to the type of brush the subject is using or to the group they are assigned to (treatment or control).
Primary Purpose: Treatment
Official Title: Safety and Efficacy of the ToothWave™ (Model H7001) Home Use Device for Calculus Reduction and Prevention of Calculus Accumulation
Actual Study Start Date : July 15, 2020
Actual Primary Completion Date : December 10, 2020
Actual Study Completion Date : December 10, 2020
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Treatment group
The treatment is conducted with the ToothWave toothbrush Intervention: brushing with Radio frequency (RF)-utilizing powered toothbrush
 Device: RF-utilizing powered toothbrush
RF-utilizing Powered toothbrush
Other Name: RF toothbrush
Experimental: Control group
Regular powered toothbrush Intervention: brushing with a regular powered toothbrush with no RF
 Device: Control placebo with no RF
Placebo control, toothbrush with no RF


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Calculus [ Time Frame: 6-12 weeks ]
    A significant calculus reduction in the treatment group as compared to the control group following 6 or 12 weeks of treatment.


Secondary Outcome Measures :
  1. reduction of calculus compared to baseline [ Time Frame: 6-12 weeks ]
    reduction in the treatment group as compared to baseline following 12 weeks of treatment

  2. Oral health [ Time Frame: 12 weeks ]
    Subjective impression by study participants in their oral health status in the treatment group following 12 weeks of treatment.

  3. prevention of calculus accumulation [ Time Frame: 6-12 weeks ]
    prevention of calculus accumulation in the treatment group as seen by no significant increase in calculus score as compared to baseline.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria

  1. Adult subjects aged 18 years and older, that are in good health.
  2. Subject must have a minimum of 16 natural teeth, including six mandibular anterior teeth with no crowns or veneers.
  3. The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
  4. The subjects should be willing to comply with the study procedures and schedule, including the follow up visits.
  5. Subjects must demonstrate a propensity for calculus formation as evidenced by at least 9 mm of calculus on the lingual surfaces of the six mandibular teeth, following the 2-month run-in phase.

Exclusion Criteria

  1. Subjects who had a medical condition requiring antibiotic premedication prior to dental procedures.
  2. Regular users of a chlorhexidine mouthrinse.
  3. Any oral condition or pathosis that could interfere with study compliance and/or examination procedures (e.g., widespread caries, chronic neglect, advanced periodontal dis-ease).
  4. Current or history of oral cavity cancer or oropharyngeal cancer.
  5. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
  6. Pregnant or nursing by subject report.
  7. Subjects that do not brush regularly.
  8. Any condition that might make it unsafe for the subject to participate in this study, at the discretion of the investigator.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04596761


Locations
Layout table for location information
United States, Indiana
Salus Research
Fort Wayne, Indiana, United States, 46825
Sponsors and Collaborators
Home Skinovations Ltd.
Investigators
Layout table for investigator information
Principal Investigator: Jeffery L Milleman, DDS, MPA Salus Research
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Home Skinovations Ltd.
ClinicalTrials.gov Identifier: NCT04596761    
Other Study ID Numbers: DO117427A
First Posted: October 22, 2020    Key Record Dates
Last Update Posted: April 23, 2021
Last Verified: March 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: Yes
Additional relevant MeSH terms:
Layout table for MeSH terms
Gingivitis
Dental Calculus
Calculi
Infections
Gingival Diseases
Periodontal Diseases
 Mouth Diseases
Stomatognathic Diseases
Pathological Conditions, Anatomical
Dental Deposits
Tooth Diseases